Biosimilar Platform IBP Lead — Strategic Execution

Sandoz

Comunidad de Madrid

Hybrid

EUR 120,000 - 180,000

Full time

13 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Sandoz is at an exciting phase of growth as a global leader in biosimilars and generics. We seek a Biosimilar Platform IBP Execution Lead to drive end-to-end IBP processes, ensuring alignment across planning forums and clear inputs for Platform and Corporate S&OP.

You will interface with senior stakeholders across regions, lead platform trade-off decisions, and coach Platform IBP managers, shaping the future of our biosimilars strategy and market access.

Qualifications

  • 10–15+ years in commercial, finance or integrated planning roles.
  • Strong experience in IBP / S&OP leadership roles.
  • Proven experience in the biosimilars market, including strategic launch planning.
  • Proven track record in cross-functional integration and decision-making.
  • Experience operating at senior stakeholder level (global / regional leadership).
  • Strong understanding of end-to-end supply chain and business drivers.

Responsibilities

  • Own end-to-end integration across IBP forums (P&PR, DR, SR, S&OP).
  • Ensure cross-functional alignment between commercial, supply chain and finance.
  • Structure platform-level trade-offs, risks and scenarios.
  • Ensure decision readiness for Platform and Corporate S&OP.
  • Act as primary interface to senior stakeholders across functions and regions.
  • Resolve cross-functional conflicts and misalignments.
  • Ensure consistency across platforms (in collaboration with other IBP leads).
  • Guide and coach Platform IBP Managers.

Skills

IBP/S&OP leadership
Cross-functional integration
Stakeholder management
Biosimilars experience
Supply chain understanding
Financial acumen
Negotiation

Job description

Sandoz is at an exciting phase of growth as a global leader in biosimilars and generics. We seek a Biosimilar Platform IBP Execution Lead to drive end-to-end IBP processes, ensuring alignment across planning forums and clear inputs for Platform and Corporate S&OP.

You will interface with senior stakeholders across regions, lead platform trade-off decisions, and coach Platform IBP managers, shaping the future of our biosimilars strategy and market access.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Biosimilar IBP Platform Lead — Global Strategy & Delivery
Biosimilar IBP Platform Lead — Global Strategy & Delivery

(FCRS = BR012) SANDOZ DO BRASIL IND FARMACEUTICA LTDA • Madrid

Hybrid
EUR 110,000 - 160,000
Biosimilar IBP Execution Lead — Platform & S&OP Champion
Biosimilar IBP Execution Lead — Platform & S&OP Champion

Sandoz International GmbH • Madrid

On-site
EUR 75,000 - 95,000
Biosimilar Platform IBP Lead — End-to-End Planning
Biosimilar Platform IBP Lead — End-to-End Planning

ES14 (FCRS = ES014) Sandoz Farmacéutica, S.A. • Madrid

On-site
EUR 80,000 - 100,000
Biosimilar Platform IBP Execution Lead
Biosimilar Platform IBP Execution Lead

ES14 (FCRS = ES014) Sandoz Farmacéutica, S.A. • Madrid

On-site
EUR 80,000 - 100,000
Biosimilar Platform IBP Execution Lead
Biosimilar Platform IBP Execution Lead

Sandoz International GmbH • Madrid

On-site
EUR 75,000 - 95,000
Biosimilar Platform IBP Execution Lead
Biosimilar Platform IBP Execution Lead

ES14 (FCRS = ES014) Sandoz Farmacéutica, S.A. • Madrid

On-site
EUR 70,000 - 90,000
Biosimilar Platform IBP Execution Lead
Biosimilar Platform IBP Execution Lead

Sandoz • Comunidad de Madrid

Hybrid
EUR 120,000 - 180,000
Biosimilar Platform IBP Execution Senior Manager
Biosimilar Platform IBP Execution Senior Manager

ES14 (FCRS = ES014) Sandoz Farmacéutica, S.A. • Madrid

On-site
EUR 70,000 - 90,000
Biosimilar Platform IBP Execution Lead
Biosimilar Platform IBP Execution Lead

(FCRS = BR012) SANDOZ DO BRASIL IND FARMACEUTICA LTDA • Madrid

Hybrid
EUR 110,000 - 160,000
Global Director, Biosimilar Platform & Pipeline Strategy
Global Director, Biosimilar Platform & Pipeline Strategy

ES14 (FCRS = ES014) Sandoz Farmacéutica, S.A. • Madrid

On-site
EUR 180,000 - 230,000